Ivabradine for the prevention of inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator | Zendy

Ar Adler | Zendy; Raphaël Rosso | Zendy; Ilana Meir | Zendy; Sami Viskin | Zendy

Open Access

Ivabradine for the prevention of inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator

Author(s) -

Ar Adler,

Raphaël Rosso,

Ilana Meir,

Sami Viskin

Publication year - 2012

Publication title -

ep europace

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.119

H-Index - 102

eISSN - 1532-2092

pISSN - 1099-5129

DOI - 10.1093/europace/eus343

Subject(s) - ivabradine , medicine , cardiology , sinus tachycardia , tachycardia , implantable cardioverter defibrillator , ventricular tachycardia , sinus rhythm , concomitant , coronary sinus , anesthesia , heart rate , atrial fibrillation , blood pressure

Ivabradine is a specific blocker of the pacemaker current (I(f)) used to decrease the sinus rate. Several clinical trials have shown that it is beneficial, with or without concomitant beta-blocker therapy, in patients with stable angina or heart failure. We sought to take advantage of ivabradine's ability to decrease the maximal obtainable sinus rate in order to prevent inappropriate shocks due to sinus tachycardia in patients with an implanted cardioverter defibrillator (ICD).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research